In 1998, an estimated 13,700 women developed invasive cervical cancer, and about 4,900 women died from the disease. More than 25 percent of invasive cervical cancer cases occur in women older than 65, and 40 to 50 percent of all women who die from cervical cancer are over 65 years of age. The Pap test, while key in decreasing cervical cancer in women, is not as accurate in diagnosing disease as previously believed. The evidence reveals that a single Pap test may miss abnormal cells in nearly half of the women who have abnormal cell growth. Available data on the accuracy of the three technologies studied fail to describe reliable estimates for reducing false positives.
Evidence related to the accuracy of the newer technologies is incomplete.
When initial and rescreening intervals are lengthened to every 3 years or greater, the new technologies were more cost-effective than the traditional Pap test. These longer screening intervals result in lowering the costs per year of life saved. Urinary tract infections in paralyzed people. Although research does indicate that prophylactic antibiotics reduce the amount of bacteria present, their use can double the development of bacteria that are resistant to the drugs. Diseases of the urinary system are the fifth most common cause of death for people with SCIs.